Physician profile
James Jared Speakman
NPI 1639279573
$14,563.99
in general payments reported to CMS, 2019-2025
20 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $8,666 · 2021: $5,171 · 2022: $114 · 2023: $52.62 · 2024: $188 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $381.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,660.68 | 2020-2021 | |
| Tela Bio, INC. | $158.28 | 2022-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $106.64 | 2020-2024 | Echelon Circular, Echelon; Endopath, Echelon Flex |
| Kci USA, INC. | $82.43 | 2019 | |
| Zimmer Biomet Holdings, INC. | $65.85 | 2020 | |
| Boston Scientific Corporation | $64.33 | 2021-2025 | Overstitch Nxt Endoscopic Suturing System |
| Organogenesis INC. | $59.80 | 2025 | Puraply Wound Matrix |
| Covidien LP | $48.67 | 2019 | |
| Medtronic, INC. | $41.65 | 2024 | Signia |
| Davol INC. | $41.38 | 2022-2025 | Phasix Mesh |
| Microline Surgical INC | $31.64 | 2022-2024 | |
| Kls-Martin L.P. | $30.44 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $27.60 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.79 | 2021 | |
| Portola Pharmaceuticals, LLC | $23.38 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $22.65 | 2019 | |
| Braintree Laboratories, INC. | $19.33 | 2019 | |
| Digestive Care, INC. | $18.68 | 2024 | Pertzye |
| Shire North American Group INC | $18.59 | 2019 | |
| Solventum Corporation | $17.18 | 2025 | Activ.A.C., Abthera Advance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Speakman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.